Sep 11, 2019 / 05:35PM GMT
David Ryan Lewis - Morgan Stanley, Research Division - MD
Let's get going here. My name is David Lewis, Medical Device Analyst here at Morgan Stanley, thanks for sticking with us here as you progress into the afternoon at Day 3 of our 2019 Healthcare Conference. It's my pleasure to have with us here the CEO of ViewRay, Scott Drake. And Scott, I thought before we get into some of the strategic questions, which I think are much more interesting fundamentally long-term, I want to try to deal with a topic at hand, obviously, which is the quarter, right?
Questions and Answers:
David Ryan Lewis - Morgan Stanley, Research Division - MDI think the fundamental question which you've been hearing about a year, the -- there's consistent commercial momentum in this business for 4 straight quarters. And this last quarter, there was a bit of a disconnect in terms of order growth, which obviously had a significant impact on the stock price. Can we just see a breakdown of what you saw on the quarter and what changed?
Scott William Drake -
Trustpilot
